{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 14,
        "end": 18
      }
    },
    {
      "id": "T2",
      "obj": "Disease",
      "span": {
        "begin": 105,
        "end": 110
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 153,
        "end": 181
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 153,
        "end": 161
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "26471290_13",
  "text": "CONCLUSIONS : KRAS MT are not associated with inferior progression-free and overall survival in advanced NSCLC patients treated with standard first-line platinum -based chemotherapy ."
}
